We are live on ! Find out more
Vanguard Capital Management

Vanguard Capital Management Portfolio holdings

AUM $4.68T
This Fund
S&P 500
This Quarter Est. Return
-1.1%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.04T
AUM Growth
–
Cap. Flow
+$4.22T
Cap. Flow %
104.32%
Top 10 Hldgs %
32.57%
Holding
4,062
New
4,061
Increased
–
Reduced
–
Closed
–
Avg Time Held
0 quarters
Top 10 Avg Time Held
0 quarters
Top 20 Avg Time Held
0 quarters

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$282B
2
AAPL icon
Apple
AAPL
+$248B
3
MSFT icon
Microsoft
MSFT
+$202B
4
AMZN icon
Amazon
AMZN
+$139B
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$119B

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 31.5%
2 Financials 12.85%
3 Healthcare 9.92%
4 Consumer Discretionary 9.89%
5 Communication Services 9.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
IHT
3951
InnSuites Hospitality Trust
IHT
$15.2M
$35.7K ﹤0.01%
+35,317
New +$40.8K
2026 Q1
0 quarters
PMCB icon
3952
PharmaCyte Biotech
PMCB
$4.4M
$34.2K ﹤0.01%
+51,467
New +$39.4K
2026 Q1
0 quarters
SEGG
3953
Sports Entertainment Gaming Global Corp
SEGG
$7.66M
$34K ﹤0.01%
+7,708
New +$59.1K
2026 Q1
0 quarters
ATER icon
3954
Aterian
ATER
$11.6M
$32.7K ﹤0.01%
+57,047
New +$37.3K
2026 Q1
0 quarters
PCSA icon
3955
Processa Pharmaceuticals
PCSA
$4.47M
$32.1K ﹤0.01%
+12,729
New +$34.8K
2026 Q1
0 quarters
CENN icon
3956
Cenntro
CENN
$9.31M
$32.1K ﹤0.01%
+4,452
New +$35K
2026 Q1
0 quarters
MBRX icon
3957
Moleculin Biotech
MBRX
$9.68M
$31.8K ﹤0.01%
+13,869
New +$45.9K
2026 Q1
0 quarters
NXGL icon
3958
NexGel
NXGL
$1.62M
$31K ﹤0.01%
+48,920
New +$60.4K
2026 Q1
0 quarters
BMRA icon
3959
Biomerica
BMRA
$9.89M
$30.6K ﹤0.01%
+14,514
New +$33.2K
2026 Q1
0 quarters
SOPA
3960
DELISTED
Society Pass
SOPA
$30.5K ﹤0.01%
+70,700
New +$98.9K
2026 Q1
0 quarters
CHGA
3961
Change Agents Corp
CHGA
$2.74M
$30.4K ﹤0.01%
+2,866
New +$47.5K
2026 Q1
0 quarters
CWD icon
3962
CaliberCos
CWD
$5.92M
$30.3K ﹤0.01%
+26,344
New +$34K
2026 Q1
0 quarters
BOLT icon
3963
Bolt Biotherapeutics
BOLT
$6.74M
$28.5K ﹤0.01%
+7,060
New +$36.8K
2026 Q1
0 quarters
AWX icon
3964
Avalon Holdings
AWX
$9.59M
$27.6K ﹤0.01%
+10,649
New +$28.1K
2026 Q1
0 quarters
CETX icon
3965
Cemtrex
CETX
$3.51M
$27K ﹤0.01%
+4,325
New +$62.3K
2026 Q1
0 quarters
IPST
3966
IP Strategy Holdings
IPST
$2.29M
$26.8K ﹤0.01%
+5,076
New +$93.4K
2026 Q1
0 quarters
GBR icon
3967
New Concept Energy
GBR
$3.99M
$26.8K ﹤0.01%
+33,021
New +$27.8K
2026 Q1
0 quarters
KRSA
3968
Korsana Biosciences, Inc. Common Stock
KRSA
$1.38B
$24.8K ﹤0.01%
+2,305
New +$23K
2026 Q1
0 quarters
SNAL icon
3969
Snail Inc
SNAL
$18.8M
$24.4K ﹤0.01%
+9,535
New +$32.4K
2026 Q1
0 quarters
YHGJ icon
3970
Yunhong Green CTI Ltd
YHGJ
$7.04M
$24.2K ﹤0.01%
+8,707
New +$28.4K
2026 Q1
0 quarters
HOST
3971
Host Digital Inc.
HOST
$3.36M
$22.9K ﹤0.01%
+2,627
New +$26.4K
2026 Q1
0 quarters
OSRH
3972
DELISTED
OSR Health
OSRH
$22.5K ﹤0.01%
+37,373
New +$20.2K
2026 Q1
0 quarters
ACON icon
3973
Aclarion
ACON
$7M
$22.2K ﹤0.01%
+6,782
New +$23.2K
2026 Q1
0 quarters
XAIR icon
3974
Beyond Air
XAIR
$2.84M
$22K ﹤0.01%
+1,597
New +$33.8K
2026 Q1
0 quarters
VIVS
3975
VivoSim Labs
VIVS
$2.63M
$22K ﹤0.01%
+15,371
New +$30.1K
2026 Q1
0 quarters

Similar funds

Vanguard Capital Management's Q1 2026 Portfolio in Review

Q1 2026 is the first quarter with a 13F filing on record for Vanguard Capital Management, which disclosed 4,062 positions worth $4.04T. Its ten largest holdings account for 33% of the portfolio.

Its largest position is NVIDIA: 1,538,550,382 shares worth $268B.

By sector, the portfolio is most concentrated in Technology at 31% of assets, followed by Financials and Healthcare.

  • Vanguard Capital Management's largest Q1 2026 buy was NVIDIA: 1,538,550,382 shares worth $268B.
  • Vanguard Capital Management's ten largest holdings make up 33% of its $4.04T portfolio in Q1 2026.
  • Vanguard Capital Management disclosed 4,062 positions in Q1 2026, its first 13F filing on record.

Based on Vanguard Capital Management's 13F filing for Q1 2026, filed 8 May 2026.